Delivery Order SPE2DB22D3004-SPE2DB23FRJ83
- Not listed
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of VYEPTI 100 MG/ML VIALML, a medical product, with a ceiling value of $8,100.26 and a period of performance through July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,405.06 firm fixed price delivery order is for VYEPTI 100 MG/ML VIALML, a specialty pharmaceutical product. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a $57,859.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Vyepti 100 mg/mL vials, a specialty pharmaceutical medication. The contract has a ceiling value of $2,314.36 and a period of performance ending on June 13, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category....
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Vyepti 100 mg/ml vials, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,471.54 and a performance period through July 3, 2025. The contract is not set aside and was awarded on June 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This federal contract award is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,471.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 14, 2025 and was awarded on February 21, 2025. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a...
- This delivery order, awarded to AmerisourceBergen Drug Corp on October 21, 2025, represents a competitive procurement of VYEPTI 100 mg/ml vial medication with a ceiling value of $3,471.51. The contract is a firm fixed price delivery order with an ultimate completion date of November 12, 2025, and is funded by the Defense Logistics Agency (DLA) under the Department of Defense. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a $69,431 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of October 6, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a major pharmaceutical distributor providing comprehensive medical...
- The Defense Logistics Agency awarded a $92,574.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of VYEPTI 100 mg/mL vial medication, with completion targeted for October 15, 2025. This is a non-set-aside, competitively awarded contract leveraging AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract will be...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $12,792.51. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with an Ultimate Completion Date of June 17, 2025. The contract is not set aside and allows for open competition....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FRJ83Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the procurement of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has a ceiling value of $3,141.00 and an ultimate completion date of October 12, 2023. It is a firm fixed price contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/20/23 |